Results 201 to 210 of about 18,473 (221)

O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer’s disease and related tauopathies: analysis of the patent literature

Expert Opinion on Therapeutic Patents, 2021
Andrés A Trabanco, Peter Buijnsters
exaly  

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

International Journal of Molecular Sciences, 2021
Jozef Hanes
exaly  

In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies

Movement Disorders, 2021
Johannes Levin, Yuan Shi, Günter U Höglinger   +2 more
exaly  

Tauopathy

2011
Frank Gaillard, Rohit Sharma, Arlene Campos   +2 more
openaire   +2 more sources

mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies

Aging Cell, 2013
Salvatore Oddo, Andrea Magri, Manuel F. Lopez-Aranda   +2 more
exaly  

Inflammasome insight in tauopathies

Nature Reviews Neurology, 2022
openaire   +2 more sources

Tauopathies

2005
openaire   +3 more sources

Tauopathies

2010
R. Simões, I. Litvan
openaire   +1 more source

Tauopathies

2013
Jennifer L. Whitwell, Keith A. Josephs
openaire   +1 more source

AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies

Acta Neuropathologica, 2010
Dennis W. Dickson, Peter Davies, Philippe Marambaud   +2 more
exaly